Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization
Clinical Trial Grant
Awarded By
HeartFlow, Inc.
Start Date
October 11, 2019
End Date
January 17, 2024
Awarded By
HeartFlow, Inc.
Start Date
October 11, 2019
End Date
January 17, 2024